A clinical trial to study the effects of two drugs, Amrutadi Kwath and Kaishor Guggul in patients with Vatarakta with special reference to Hyperuricaemia.

An Open Randomized Comparative clinical study of Amrutadi kwath (Sharangdhar samhita) with Kaishor guggul (Sharangdhar samhita) in the management of Vatarakta with special reference to Hyperuricemia. - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065911

Enrollment

Registered

2024-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All genders will be included Age group 18 to 70 years All patients clinically diagnosed as vatarakta Hyperuricemic patients Patient having uric acid level 6.5 to 12 mg per dl

Exclusion criteria

Exclusion criteria: 1) Patients with renal failure 2) Pregnant and lactating mother 3) patients with known case HIV and leprosy

Design outcomes

Primary

Measure	Time frame
Sr. Uric acidTimepoint: 21 days	—

Secondary

Measure	Time frame
Sandhishula Sandhigraha Sandhitamravarnata Sandhisparshasahatva Sandhikriyakashtata Sandhishotha DahaTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr. Ashwini Harish Agrawal

APMs, Ayurveda Mahavidyalay sion, Mumbai

anayapathrikar@gmail.com9870214595

Outcome results